Global Counterfeit Drug Detection Device Market
Counterfeit Drug Detection Device Market size is estimated at USD 1.5 billion in 2024 and is expected to cross USD 3 billion by the end of 2037, expanding at more than 5.4% CAGR during the forecast period i.e., between 2025-2037. In 2025, the industry size of counterfeit drug detection device is evaluated at USD 1.6 billion.
The global counterfeit drug detection device market is witnessing expansion due to the increasing prevalence of counterfeit drugs, which pose strong risks to consumers' health and undermine the integrity of healthcare systems around the globe. Thus, as counterfeit medication becomes increasingly sophisticated and difficult to detect, the urgency grows for effective detection solutions that can be necessary and sufficient to assure patient safety and preserve public trust in pharmaceutical products.
To meet the demand gap, companies in the market are developing advanced technologies to detect counterfeit drugs. For instance, in March of 2023, InVita Healthcare Technologies launched Pharma Defense, the first-of-its-kind to focus specifically on testing counterfeits, a drug that will help gain the upper hand in the battle against pharmacy fraud. Additionally, governments across the world are implementing strict anti-counterfeit measures and investing in advanced detection technologies to ensure public health, thus fueling counterfeit drug detection device market growth.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
5.4% |
|
Base Year Market Size (2024) |
USD 1.5 billion |
|
Forecast Year Market Size (2037) |
USD 3 billion |
|
Regional Scope |
|
Modality (Portable Devices, Handheld Devices, Benchtop Devices)
Portable devices segment in the counterfeit drug detection device market is anticipated to register around 5.7% growth till 2037 due to the increasing demand for portable as well as cost-effective, user-friendly detection solutions. Another driver of portable devices is their ability to provide immediate, easy on-site detection of counterfeit medicines, hence convenient for use at all places, including pharmacies, hospitals, and border control points.
End user (Pharmaceutical Companies, Drug Testing Laboratories, Research Organizations)
Drug testing laboratories segment is set to capture over 59.8% counterfeit drug detection device market share by 2037. The adoption of counterfeit drug detection device is rising in drug testing laboratories as they ensure the safety and efficacy of drugs by means of stringent testing and analysis of drug products. It has increased the requirement for accurate and reliable testing services and advanced detection technologies. Laboratories' collaboration with regulatory agencies helps enhance the validation of the detection methods involved, which further pushes up the standard in the industry. As counterfeit drugs continue flooding into the market, labs continue to bolster their arsenal with advanced technologies. Such progress improves their operations and makes them more responsive to this growing threat.
Our in-depth analysis of the counterfeit drug detection device market includes the following segments
|
Product |
|
|
Modality |
|
|
End user |
|
North America Market Analysis
North America counterfeit drug detection device market is anticipated to account for revenue share of around 34.2% by 2037. Some of the primary drivers include awareness of the dangers of counterfeit drugs and improvement in healthcare infrastructure. The region has a highly regulated pharmaceutical market, offering strict policies wherein advanced technologies are used to detect counterfeit drugs. The growing demand for medicines through e-commerce and online pharmacies elevates the need for strong authentication methods of drugs.
In the U.S., government initiatives are driving the demand for counterfeit drug detection device market. The U.S. government imposed strict regulations against counterfeit drugs, which indeed influenced a massive scale in the dynamics of the market. For example, Section 27 of R.A. 3720 provides that the U.S. FDA thoroughly checks and verifies pharmaceuticals, which promotes the buying and use of detection apparatus. Aside from its influence on market growth, these regulations also help consumers avoid buying defective and harmful counterfeit products.
Canada has strict health-related regulations with rampant cases of false pharmaceutical drugs that have notably played a role in easing some drug-related safety concerns. The government has budgeted USD 150 million in fiscal year 2024 toward stricter regulation of policies related to drug safety, an effort to combat rogue medications. It detects and eliminates false drugs before they get to the last consumer; therefore, it causes demand for identification technologies.
Asia Pacific excluding Japan Market Statistics
Till 2037, Asia Pacific excluding Japan counterfeit drug detection device market is anticipated to showcase growth rate of around 6.2% owing to increasing cases of counterfeit pharmaceuticals in the region. The recent adaptation of online e-commerce has increased the demand for portable, efficient, and convenient drug detection technologies. Authenticating medications becomes more relevant as more people buy their drugs from online pharmacies. Thus, the urgent need for effective counterfeit detection solutions in the APEJ has increased.
In India, the government has already initiated measures to counter the problem of counterfeit drugs. Health infrastructure upgrade provisions made by the government in the budget of 2024-25 amount to USD 10.66 million, primarily in the form of the upgradation of hospitals and clinics. This can be accompanied by smart detection technologies to provide better safety to patients and authenticity of drugs. High e-commerce in India has propelled the demand for reliable verification methods for drugs.
In China, strict regulatory measures are considered in dealing with this emerging issue of counterfeit drugs to make a more secure pharmaceutical environment. In 2023, fake drugs in China rose by 22% compared to the previous year. Advanced detection technology is becoming widespread considering the rise in consumer preference toward e-commerce platforms. The counterfeit drug detection device market in China is anticipated to expand with widened consumer consciousness and government initiatives on detection devices for spurious drugs.
The counterfeit drug detection device market is highly competitive, with the presence of some major key players trying to vie for market share. Key players including B&W Tek, Metrohm AG, Thermo Fisher Scientific Inc., and Rigaku Corporation, are actively developing research and development to come up with innovations and technologically advanced solutions to detect counterfeit drugs.
These companies are also focusing on strategic partnerships, mergers, and acquisitions to expand their presence in the market and expand their portfolios of products. In December 2021, Thermo Fisher Scientific Inc. acquired a leading provider of portable chemical analysis solutions step in strengthening its position in the counterfeit drug detection device market. It will significantly expand the customer base and the portfolio of Thermo Fisher's product line, boosting the competition in the market.
Here are some leading companies in the counterfeit drug detection device market
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?